Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Feldman

Sports Medicine Coral Springs, FL Medical Doctor

NPI 1609131754 CMS profile 3703917

10139 Nw 31St St Ste 202, Coral Springs, FL 33065

Open in the dashboard

General payments

$11,624

123 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Feldman of Coral Springs, FL is reported in the CMS Open Payments database as having received $11,624 across 123 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 59th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,692 24
2024 General $635 15
2023 General $645 8
2022 General $441 7
2021 General $1,300 21
2020 General $3,002 20
2019 General $3,909 28

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Feldman
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to John Feldman were reported at $1,692. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year John Feldman Sports Medicine median Middle half National median
2019 $3,909 $1,176 $199–$4,249 $163
2020 $3,002 $708 $96–$2,890 $114
2021 $1,300 $1,213 $152–$3,994 $132
2022 $441 $1,230 $159–$3,998 $149
2023 $645 $584 $146–$2,836 $160
2024 $635 $628 $163–$3,168 $164
2025 $1,692 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $5,934 43 payments
  2. Arthrex, Inc. $1,541 6 payments
  3. Stryker Corporation $1,044 11 payments
  4. DePuy Synthes Sales Inc. $690 15 payments
  5. Medical Device Business Services, Inc. $489 6 payments
  6. Kyocera Medical Technologies, Inc. $347 1 payment
  7. Flexion Therapeutics, Inc. $225 5 payments
  8. Southern Edge Orthopaedics, Inc. $166 1 payment
  9. Next Science LLC $157 1 payment
  10. SeaPearl Inc $153 2 payments
  11. Other $878 32 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,145 111 payments
  2. Travel and Lodging $4,236 11 payments
  3. Education $1,242 1 payment
Products named General payments · program years 2019–2025
  1. Hipstruments $2,267 8 payments
  2. Q-FIX Hip $2,117 7 payments
  3. Healicoil $999 1 payment
  4. ACCUPASS DIRECT Crescent XL $475 2 payments
  5. Hip Positioning System $442 3 payments
  6. MAKO $327 4 payments
  7. EVOS $326 3 payments
  8. MAVERICK $308 3 payments
  9. Journey II BCS $299 3 payments
  10. REDAPT Revision Hip System $299 3 payments
  11. Other $5,433 107 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

252

Median for Orthopedic Surgery: 203

Drug cost

$1,702

Median for Orthopedic Surgery: $1,433

Branded share of claims

15.1%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 110 $1,087
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 38 $250
Tramadol Hcl Generic 67 $184
Methylprednisolone Generic 26 $134
Oxycodone Hcl Generic 11 $46

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 109 billing codes

Paid by Medicare

$157,686

Of which drugs: $3,711

Medicare patients

383

Average age 80

Services billed

2,147

247 women, 136 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 67%
Ischemic heart disease 45%
Chronic kidney disease 37%
Depression 35%
Osteoporosis 32%
Diabetes 31%
Atrial fibrillation 24%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 55 130 $652
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 20 96 $8

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

123 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record